P Barton Duell Selected Research

Cerebrotendinous Xanthomatosis

7/2021	Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935-2020).
1/2021	Update on cerebrotendinous xanthomatosis.
1/2021	Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
11/2019	Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral Cataracts.
10/2018	Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma.
9/2018	Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis.
12/2017	Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.
5/2011	Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Barton Duell Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 07/2016
14	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 05/2015
9	Hypercholesterolemia 05/2022 - 12/2016
8	Cerebrotendinous Xanthomatosis 07/2021 - 05/2011
4	Cataract (Cataracts) 07/2021 - 12/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2004
3	Homozygous Familial Hypercholesterolemia 08/2021 - 12/2016
3	Dyslipidemias (Dyslipidemia) 11/2020 - 03/2019
3	Myocardial Infarction 10/2019 - 07/2016
2	Acute Coronary Syndrome 05/2022 - 03/2020
2	Atherosclerosis 01/2022 - 01/2022
2	Xanthomatosis (Xanthoma) 07/2021 - 09/2018
2	Heart Diseases (Heart Disease) 07/2021 - 05/2015
2	Insulin Resistance 05/2021 - 09/2004
2	Disease Progression 01/2021 - 01/2021
2	Gout 10/2020 - 09/2020
2	Pancreatitis 03/2020 - 01/2018
2	Stroke (Strokes) 10/2019 - 01/2019
2	Ischemic Stroke 01/2019 - 07/2016
2	Coronary Disease (Coronary Heart Disease) 06/2016 - 11/2005
1	Prediabetic State (Prediabetes) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Lipidoses 01/2022
1	Thrombosis (Thrombus) 01/2022
1	COVID-19 08/2021
1	Acromegaly 08/2021
1	Respiratory Insufficiency (Respiratory Failure) 08/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2021
1	Diarrhea 07/2021
1	Intellectual Disability (Idiocy) 07/2021
1	Thrombocytopenia (Thrombopenia) 07/2021
1	Splenomegaly 07/2021
1	Anemia 07/2021
1	Smith-Lemli-Opitz Syndrome 07/2021
1	Sitosterolemia 07/2021
1	Hyperglycemia 09/2020
1	Myalgia 09/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hyperuricemia 11/2019
1	Nasopharyngitis 11/2019
1	Urinary Tract Infections (Urinary Tract Infection) 11/2019
1	Transient Ischemic Attack 10/2019
1	Erectile Dysfunction 01/2019
1	Rhabdomyolysis 01/2019
1	Cognitive Dysfunction 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Hemorrhagic Stroke 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Tendinopathy (Tendonitis) 01/2019
1	Neoplasms (Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

18	LipidsIBA 05/2022 - 09/2004
13	LDL CholesterolIBA 05/2022 - 11/2005
12	oxidized low density lipoproteinIBA 05/2022 - 05/2016
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 05/2016
6	Lipoproteins (Lipoprotein)IBA 01/2022 - 09/2004
5	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 05/2022 - 11/2019
4	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 05/2011
4	Triglycerides (Triacylglycerol)IBA 11/2020 - 09/2004
3	Cholestanol (Coprostanol)IBA 07/2021 - 09/2018
3	CholesterolIBA 07/2021 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2016
3	mipomersenIBA 01/2019 - 07/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2004
2	Biological ProductsIBA 05/2021 - 07/2020
2	HDL CholesterolIBA 11/2020 - 03/2020
2	EnzymesIBA 10/2020 - 10/2018
2	Proprotein Convertase 9IBA 03/2020 - 01/2020
2	Apolipoproteins B (ApoB)IBA 01/2020 - 12/2016
2	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 11/2019 - 09/2018
2	omega-Chloroacetophenone (Mace)IBA 10/2019 - 07/2016
2	SterolsIBA 10/2018 - 05/2011
2	CarbohydratesIBA 11/2005 - 09/2004
1	erucic acidIBA 01/2022
1	Lipoprotein(a)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 08/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 08/2021
1	evinacumabIBA 08/2021
1	disalicylaldehyde ethylenediamine (salen)IBA 07/2021
1	gamma-sitosterol (beta-sitosterol)IBA 07/2021
1	Metformin (Glucophage)FDA LinkGeneric 03/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Uric Acid (Urate)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 07/2020
1	Monoclonal AntibodiesIBA 03/2020
1	ApolipoproteinsIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	CholestanolsIBA 11/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2019
1	SubtilisinIBA 01/2019

Therapy/Procedure

9	Therapeutics 05/2022 - 06/2016
2	Secondary Prevention 11/2020 - 03/2020
2	Blood Component Removal (Apheresis) 01/2019 - 05/2016
2	Fat-Restricted Diet (Diet, Fat Restricted) 11/2005 - 09/2004
1	Intravenous Administration 08/2021
1	Organ Transplantation 03/2020
1	Continuity of Patient Care 03/2019